Epigenetic Modifications of Immune Cells and their Importance for Alloimmunity

Wednesday, September 12, 2018 - 14:00 to 15:00

View Archive

Speaker: Andrew Wells, PhD • University of Pennsylvania and CHOP
Moderator: Jonathan Maltzman, MD, PhD • Stanford University

After participating in this webinar, the learner will be able to:

  1. Define epigenetics, outline basic concepts and processes.
  2. Outline examples of DNA methylation controlling T cell function.
  3. Outline examples of histone modifications controlling T cell function.
  4. Describe examples of epigenetic factors contributing to organ transplant rejection in rodent models.
  5. Describe a clinical example of epigenetic drug targeting in allogenic bone marrow transplantation to alleviate GVHD.
  6. Outline basic concepts in genomics and epigenomics.
  7. Describe 3-dimensional regulatory architectures of inflammatory genes in T cells.
  8. Discuss the use of 3D epigenomics to understand the basis of genetic susceptibility to inflammatory disease in humans.
Presenter: 
Andrew Wells, PhD
Education Category: 
Series category: 
T3: Timely Topics in Transplantion

Educational Content Disclaimer: The content, information, opinions, and viewpoints contained in educational materials housed on and linked from the AST web site are those of the authors or contributors of such materials. While the AST and its committees take great care to screen the credentials of the contributors and make every attempt to review the contents, AST MAKES NO WARRANTY, EXPRESSED OR IMPLIED, as to the completeness or accuracy of the content contained in the educational materials or on this website. The reader of these materials uses these materials at his or her own risk, and AST shall not be responsible for any errors, omissions, or inaccuracies in these materials, whether arising through negligence, oversight, or otherwise. Reliance on any information appearing on this site is strictly at your own risk. Read the full disclaimer.